{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T05:50:13Z","timestamp":1777355413421,"version":"3.51.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1996,6,1]],"date-time":"1996-06-01T00:00:00Z","timestamp":833587200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digest Dis Sci"],"published-print":{"date-parts":[[1996,6]]},"DOI":"10.1007\/bf02088245","type":"journal-article","created":{"date-parts":[[2005,8,14]],"date-time":"2005-08-14T08:43:55Z","timestamp":1124009035000},"page":"1248-1255","source":"Crossref","is-referenced-by-count":57,"title":["Interferon as treatment for acute hepatitis C"],"prefix":"10.1007","volume":"41","author":[{"given":"Calogero","family":"Camm\u00e0","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piero","family":"Almasio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Crax\u00ec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02088245_CR1","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJM199212313272702","volume":"327","author":"MJ Alter","year":"1992","unstructured":"Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, Hu PY, Miller JK, Gerber MA, Sampliner RE, Meeks EL, Beach MJ: The natural history of community-acquired hepatitis C in the United States. N Engl J Med 327:1899\u20131905, 1992","journal-title":"N Engl J Med"},{"key":"BF02088245_CR2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.7326\/0003-4819-114-4-277","volume":"114","author":"F Tremolada","year":"1991","unstructured":"Tremolada F, Casarin C, Tagger A, Ribero ML, Realdi G, Alberti A, Ruol A: Antibody to hepatitis C virus in post-transfusion hepatitis. Ann Intern Med 114:277\u2013281, 1991","journal-title":"Ann Intern Med"},{"key":"BF02088245_CR3","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S0168-8278(05)80358-7","volume":"20","author":"T Giuberti","year":"1994","unstructured":"Giuberti T, Marin MG, Ferrari C, Marchelli S, Schianchi C, Degli Antoni AM, Pizzocolo G, Fiaccadori F: Hepatitis C virus viremia following clinical resolution of acute hepatitis C. J Hepatol 20:666\u2013671, 1994","journal-title":"J Hepatol"},{"key":"BF02088245_CR4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/978-1-4684-7041-3_8","volume-title":"Current Perspective in Hepatology","author":"HJ Alter","year":"1989","unstructured":"Alter HJ: Chronic consequences of non-A, non-B hepatitis.In Current Perspective in Hepatology. LB Seef, JH Lewis (eds). New York, Plenum Publishing, 1989, pp 83\u201397"},{"key":"BF02088245_CR5","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/hep.1840040304","volume":"4","author":"G Papevangelou","year":"1994","unstructured":"Papevangelou G, Tassopoulos N, Roumeliotou-Karayannis A, Richardson C: Etiology of fulminant viral hepatitis in Greece. Hepatology 4:369\u2013372, 1994","journal-title":"Hepatology"},{"key":"BF02088245_CR6","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/0016-5085(92)90184-Z","volume":"102","author":"N Tassopoulos","year":"1992","unstructured":"Tassopoulos N, Hatzakis A, Delladetsima I, Koutelou MG, Todoulos A, Miriagou V: Role of hepatitis C virus in acute non-A, non-B hepatitis in Greece: A five year prospective study. Gastroenterology 102:969\u2013972, 1992","journal-title":"Gastroenterology"},{"key":"BF02088245_CR7","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/0168-8278(91)90935-5","volume":"12","author":"F Bortolotti","year":"1991","unstructured":"Bortolotti F, Tagger A, Cadrobbi P, Crivellaro C, Pregliasco F, Ribero ML, Alberti A: Antibodies to hepatitis C virus in community-acquired acute non-A, non-B hepatitis. J Hepatol 12:176\u2013180, 1991","journal-title":"J Hepatol"},{"key":"BF02088245_CR8","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/gut.23.4.270","volume":"23","author":"G Realdi","year":"1992","unstructured":"Realdi G, Alberti A, Rugge M: Long term follow-up of acute and chronic non A non B post transfusion hepatitis:evidence of progression to liver cirrhosis. Gut 23:270\u2013275, 1992","journal-title":"Gut"},{"key":"BF02088245_CR9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1055\/s-2008-1040432","volume":"11","author":"J Genesca","year":"1991","unstructured":"Genesca J, Esteban JI, Alter HJ: Blood-borne non-A, non-B hepatitis: hepatitis C. Semin Liver Dis 11:147\u2013164, 1991","journal-title":"Semin Liver Dis"},{"key":"BF02088245_CR10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.7326\/0003-4819-116-2-97","volume":"116","author":"RG Simonetti","year":"1992","unstructured":"Simonetti RG, Camm\u00e0 C, Fiorello F, Cottone M, Rapicctta M, Marino L, Fiorentino G, Crax\u00ec A, Ciccaglione A, Giuseppetti R, Stroffolini T, Pagliaro L: Hepatitis C infection as a risk factor for hepatocellular carcinoma in Patients with cirrhosis: A case-control study. Ann Intern Med 116:97\u2013102, 1992","journal-title":"Ann Intern Med"},{"key":"BF02088245_CR11","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/jmv.1890330309","volume":"33","author":"SD Lee","year":"1991","unstructured":"Lee SD, Tsai YT, Hwang SJ, Wu JC, Yung CH, Cheng KK, Lo KJ: A prospective study of posttransfusion non-A, non-B hepatitis (type C) hepatitis following cardiovascular surgery in Taiwan. J Med Virol 33:188\u2013192, 1991","journal-title":"J Med Virol"},{"key":"BF02088245_CR12","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0168-8278(05)80657-9","volume":"16","author":"F Tremolada","year":"1992","unstructured":"Tremolada F, Casarin C, Alberti A, Drago G, Tagger A, Ribero ML, Realdi G: Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis. J Hepatol 16:273\u2013281, 1992","journal-title":"J Hepatol"},{"key":"BF02088245_CR13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1055\/s-2008-1040795","volume":"6","author":"JL Dienstig","year":"1986","unstructured":"Dienstig JL, Alter HJ: Non-A, non-B hepatitis: Evolving epidemiologic and clinical perspective. Semin Liver Dis 6:67\u201381, 1986","journal-title":"Semin Liver Dis"},{"key":"BF02088245_CR14","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1056\/NEJM198911303212203","volume":"321","author":"GL Davis","year":"1989","unstructured":"Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC, Perrillo RP, Carey W, Jacobson IM, Payne J, Dienstag JL, Van Thiel DH, Tamburro C, Lefkowitch J, Albrecht J, Meschievitz C, Ortego TJ, Gibas A: Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized controlled trial. N Engl J Med 321:1501\u20131506, 1989","journal-title":"N Engl J Med"},{"key":"BF02088245_CR15","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM198911303212204","volume":"321","author":"AM Bisceglie Di","year":"1989","unstructured":"Di Bisceglie AM, Martin P, Kassianides C, Lisker-Melman M, Murray L, Waggoner J, Goodman Z, Banks S, Hoofnagle JH: Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double blind, placebo-controlled trial. N Engl J Med 321:1506\u20131510, 1989","journal-title":"N Engl J Med"},{"key":"BF02088245_CR16","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0168-8278(91)90814-R","volume":"13","author":"F Tin\u00e8","year":"1991","unstructured":"Tin\u00e8 F, Magrin S, Crax\u00ec A, Pagliaro L: Interferon for non-A, non-B chronic hepatitis: a metanalysis of randomized clinical trials. J Hepatol 13:192\u2013199, 1991","journal-title":"J Hepatol"},{"key":"BF02088245_CR17","first-page":"820","volume":"15","author":"L Pagliaro","year":"1994","unstructured":"Pagliaro L, Crax\u00ec A, Camm\u00e0 C, Tin\u00e8 F, Di Marco V, Lo Iacono O, Almasio P: Interferon-\u03b1 for chronic hepatitis C: an analysis of pretreatment clinical predictors of response. Hepatology 15:820\u2013828, 1994","journal-title":"Hepatology"},{"key":"BF02088245_CR18","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0016-5085(91)90030-O","volume":"101","author":"X Causse","year":"1991","unstructured":"Causse X, Godinot H, Chevallier M, Chossegros P, Zoulin F, Ouzan D, Heyraud JP, Fontanges T, Albrecht J, Meschievitz C, Trepo C: Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis. Gastroenterology 101:497\u2013502, 1991","journal-title":"Gastroenterology"},{"issue":"suppl 1","key":"BF02088245_CR19","doi-asserted-by":"crossref","first-page":"s57","DOI":"10.1016\/0168-8278(90)90165-N","volume":"11","author":"O Weiland","year":"1990","unstructured":"Weiland O, Schvarcz R, Wejstal R, Norkrans G, Fryden A: Therapy of chronic post-transfusion non-A, non-B hepatitis with interferon alfa-2b: Swedish experience. J Hepatol 11 (suppl 1):s57-s62, 1990","journal-title":"J Hepatol"},{"key":"BF02088245_CR20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/hep.1840190105","volume":"19","author":"P Lampertico","year":"1994","unstructured":"Lampertico P, Rumi M, Romeo R, Crax\u00ec A, Soffredini R, Biassioni D, Colombo M: A multicenter randomized controlled trial of recombinant interferon-\u03b1 2b in patients with acute transfusion-associated hepatitis C. Hepatology 19:19\u201322, 1994","journal-title":"Hepatology"},{"key":"BF02088245_CR21","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/hep.1840150504","volume":"15","author":"L Viladomiu","year":"1992","unstructured":"Viladomiu L, Genesc\u00e0 J, Esteban JI, Allende H, Gonz\u00e0lez A, L\u00f2pez-Talavera LC, Esteban R, Guardia J: Interferon-\u03b1 in acute posttransfusion hepatitis C: A randomized, controlled trial. Hepatology 15:767\u2013769, 1992","journal-title":"Hepatology"},{"key":"BF02088245_CR22","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0168-8278(94)80246-7","volume":"21","author":"S-J Hwang","year":"1994","unstructured":"Hwang S-J, Lee S-D, Chan C-Y, Lu R-H, Lo K-J: A randomized controlled trial of recombinant interferon\u03b1-2b in the treatment of Chinese patients with acute post-transfusion hepatitis C. J Hepatol 21:831\u2013836, 1994","journal-title":"J Hepatol"},{"key":"BF02088245_CR23","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0016-5085(94)90130-9","volume":"107","author":"S Takano","year":"1994","unstructured":"Takano S, Satomura Y, Omata M, Japan Acute Hepatitis Coop Study Group: Effects of interferon beta on non-A, non-B acute hepatitis: A prospective, randomized, controlled-dose study. Gastroenterology 107:805\u2013811, 1994","journal-title":"Gastroenterology"},{"issue":"Suppl","key":"BF02088245_CR24","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1136\/gut.34.2_Suppl.S130","volume":"34","author":"NC Tassopoulos","year":"1993","unstructured":"Tassopoulos NC, Koutelou MG, Papatheodoridis G, Polychronaki H, Delladetsima I, Giannikakis T, Todoulos A, Toliopoulos A, Hatzakis A: Recombinant human interferon alfa-2b treatment for acute non-A, non-B hepatitis. Gut 34(Suppl):S130-S132, 1993","journal-title":"Gut"},{"key":"BF02088245_CR25","first-page":"1041","volume":"86","author":"K Ohnishi","year":"1991","unstructured":"Ohnishi K, Nomura F, Nakano M: Interferon therapy for acute posttransfusion non-A, non-B hepatitis: Response with respect to anti-hepatitis C virus antibody status. Am J Gastroenterol 86:1041\u20131049, 1991","journal-title":"Am J Gastroenterol"},{"key":"BF02088245_CR26","first-page":"596","volume":"84","author":"K Ohnishi","year":"1989","unstructured":"Ohnishi K, Nomura F, Iida S: Treatment of posttransfusion non-A, non-B hepatitis acute and chronic hepatitis with human fibroblast\u03b2-interferon: A preliminary report. Am J Gastroenterol 84:596\u2013600, 1989","journal-title":"Am J Gastroenterol"},{"key":"BF02088245_CR27","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/BF01307593","volume":"37","author":"H Hagiwara","year":"1992","unstructured":"Hagiwara H, Hayashi N, Kasahara A, Mita E, Takehara T, Fusamoto H, Kamada T. Three cases of posttransfusion hepatitis C treated with interferon-\u03b1. Confirmation of a carrier state by detection of hepatitis C virus RNA after interferon therapy. Dig Dis Sci 37:631\u2013634, 1992","journal-title":"Dig Dis Sci"},{"key":"BF02088245_CR28","first-page":"429","volume":"76","author":"P Almasio","year":"1991","unstructured":"Almasio P, Mirto S, Malleo C, Di Marco V, Caronia F, Crax\u00ec A: Recombinant interferon alpha-2B for acute post-transfusion hepatitis in acute myeloid leukemia. Haematologica 76:429\u2013430, 1991","journal-title":"Haematologica"},{"key":"BF02088245_CR29","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/0140-6736(91)91774-O","volume":"338","author":"M Omata","year":"1991","unstructured":"Omata M, Yokosuka O, Takano S, Kato N, Hosoda K, Imazeki F, Tada M, Ito Y, Ohto M: Resolution of acute hepatitis C after therapy with natural beta interferon. Lancet 338:914\u2013915, 1991","journal-title":"Lancet"},{"key":"BF02088245_CR30","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/BF02033074","volume":"20","author":"NC Tassopoulos","year":"1992","unstructured":"Tassopoulos NC, Koutelou M, Papatheodoridis G, Polychronaki H, Giannikakis T, Paraloglou-Ioannides M, Hatzakis A: Treatment of acute non-A, non-B hepatitis with interferon alpha-2b. Infection 20:242, 1992","journal-title":"Infection"},{"issue":"suppl","key":"BF02088245_CR31","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1136\/gut.34.2_Suppl.S62","volume":"34","author":"J Genesca","year":"1993","unstructured":"Genesca J, Esteban JI, Quer J, Viladomiu L, Gonz\u00e0lez A, Esteban R, Guardia J: Hepatitis C virus markers in patients with acute post-transfusion hepatitis treated with interferon alfa-2b. Gut 34(suppl):S62-S63, 1993","journal-title":"Gut"},{"key":"BF02088245_CR32","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/BF01716714","volume":"22","author":"D Palmovic","year":"1994","unstructured":"Palmovic D, Kurelac I, Crnjakovic-Palmovic J: The treatment of acute post-transfusion hepatitis C with recombinant interferon-alpha. Infection 22:222\u2013223, 1994","journal-title":"Infection"},{"key":"BF02088245_CR33","unstructured":"Alberti A, Belussi F, Chemello L, Benvegn\u00f9 L, Pontisso P: Outcome of acute hepatitis C and role of interferon alpha (IFN-2a) therapy. Proceedings of the International Symposium on Viral Hepatitis and Liver Disease. Tokyo, May 10\u201314, 1993"},{"key":"BF02088245_CR34","doi-asserted-by":"crossref","unstructured":"Viladomiu L, Lopez-Talavera JC, Gonzalez A, Esteban JI, Esteban R, Guardia J: Interferon treatment in acute posttransfusion NANB hepatitis. J Hepatol 11(suppl 1):S166, 1990","DOI":"10.1016\/0168-8278(90)90196-X"},{"key":"BF02088245_CR35","doi-asserted-by":"crossref","unstructured":"Viladomiu L, Gonz\u00e0lez A, L\u00f2pez-Talavera LC, Esteban JI, Esteban R, Guardia J: Randomized controlled study of recombinant alpha-interferon therapy in acute post-transfusion hepatitis. International Symposium on Viral Hepatitis and Liver Disease. Houston, 1990, p 178","DOI":"10.1016\/0168-8278(90)90196-X"},{"key":"BF02088245_CR36","doi-asserted-by":"crossref","unstructured":"Colombo M, Lampertico P, Rumi M: Multicentre randomised controlled trial of recombinant interferon alfa-2b in patients with acute non-A, non-B\/type C hepatitis after transfusion. Gut 34(suppl):S141, 1993","DOI":"10.1136\/gut.34.2_Suppl.S141"},{"key":"BF02088245_CR37","unstructured":"Lampertico P, Rumi MG, Colombo M, Italian Study Group for Therapy of Viral Hepatitis: A randomized multicenter controlled trial of recombinant interferon-\u03b1 2b in patients with acute post-transfusion non-A, non-B hepatitis (PTH). Gastroenterology 102:A838, 1992"},{"key":"BF02088245_CR38","doi-asserted-by":"crossref","unstructured":"Chemello L, Benvegnu L, Bellusi F, Tagger A, Ruol A, Alberti A: Pilot study of interferon alpha-2a therapy in preventing chronic evolution of acute hepatitis C. J Hepatol 11(suppl 2):S81, 1992","DOI":"10.1016\/0168-8278(90)91656-H"},{"key":"BF02088245_CR39","doi-asserted-by":"crossref","unstructured":"Alberti A, Chemello L, Benvegn\u00f9 L, Bellusi F, Tagger A, Ruol A: Pilot study of interferon alpha-2a therapy in preventing chronic evolution of acute hepatitis C. International Symposium on Viral Hepatitis and Liver Disease. Houston, 1990, p 176 (abstract)","DOI":"10.1016\/0168-8278(90)91656-H"},{"key":"BF02088245_CR40","unstructured":"Omata M, Takano S: Interferon treatment for acute hepatitis C. International Symposium on Viral Hepatitis and Liver Disease, Tokyo, 1993, p 44 (abstract)"},{"key":"BF02088245_CR41","doi-asserted-by":"crossref","unstructured":"Vogel W, Umlauft F, Datz C, Judmaier G, Schneider G, Gr\u00fcnewald K: High dose interferon alpha for acute hepatitis C. Hepatology 18(Pt 2):89A, 1993","DOI":"10.1016\/0270-9139(93)91885-V"},{"key":"BF02088245_CR42","first-page":"1078","volume":"23","author":"J Germanaud","year":"1994","unstructured":"Germanaud J, Causse X, Dhumeaux D: Transmission de l'h\u00e9patite C lors de piq\u00fbres accidentelles. Evaluation du risque. Presse Med 1994;23:1078\u20131082.","journal-title":"Presse Med"},{"issue":"4","key":"BF02088245_CR43","first-page":"362","volume":"18","author":"JM Pawlotsky","year":"1994","unstructured":"Pawlotsky JM, Marcellin P, Trepo C, Dhumeaux D: Treatment of viral hepatitis C. Gastroenterol Clin Biol 18(4):362\u2013373, 1994","journal-title":"Gastroenterol Clin Biol"},{"issue":"suppl","key":"BF02088245_CR44","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1136\/gut.34.2_Suppl.S77","volume":"34","author":"R Esteban","year":"1993","unstructured":"Esteban R: Is there a role for interferon in acute viral hepatitis. Gut 34(suppl):S77-S80, 1993","journal-title":"Gut"},{"key":"BF02088245_CR45","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/hep.1840160232","volume":"16","author":"J Rakela","year":"1992","unstructured":"Rakela J, Douglas DD: Therapy of acute hepatitis C with interferon: How good is it really. Hepatology 16:497\u2013498, 1992","journal-title":"Hepatology"},{"key":"BF02088245_CR46","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/0016-5085(92)91204-H","volume":"103","author":"JB Gross","year":"1992","unstructured":"Gross JB: Selected summaries: Interferon-\u03b1 in acute posttransfusion hepatitis C: A randomized, controlled trial. Gastroenterology 103:1702\u20131703, 1992","journal-title":"Gastroenterology"},{"key":"BF02088245_CR47","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1056\/NEJM198702193160806","volume":"316","author":"HS Sacks","year":"1987","unstructured":"Sacks HS, Berrier J, Reitman D, Ancona-Berk VA, Chalmers TC: Meta-analyses of randomised controlled trials. N Engl J Med 316:450\u2013455, 1987","journal-title":"N Engl J Med"},{"key":"BF02088245_CR48","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N: Meta-analysis in clinical trials. Controlled Clin Trials 7:177\u2013188, 1986","journal-title":"Controlled Clin Trials"},{"key":"BF02088245_CR49","first-page":"719","volume":"22","author":"N Mantel","year":"1959","unstructured":"Mantel N, Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719\u2013748, 1959","journal-title":"J Natl Cancer Inst"},{"key":"BF02088245_CR50","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1056\/NEJM198805053181805","volume":"5","author":"R Collins","year":"1988","unstructured":"Collins R, Scrimgeour A, Yusuf D, Phil D, Peto R: Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin: Overview of results of randomized trials in general orthopedic and urologic surgery. N Engl J Med 5:1162\u20131173, 1988","journal-title":"N Engl J Med"},{"key":"BF02088245_CR51","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/sim.4780080202","volume":"8","author":"JA Berlin","year":"1989","unstructured":"Berlin JA, Laird NM, Sacks HS, Chalmers TC. A comparison of statistical methods for combining rates from clinical trials. Stat Med 8:141\u2013151, 1989","journal-title":"Stat Med"},{"key":"BF02088245_CR52","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0197-2456(81)90056-8","volume":"2","author":"TC Chalmers","year":"1981","unstructured":"Chalmers TC, Smith H, Blackburn B, Silverman B, Schroeder B: A method for assessing the quality of a randomized trial. Controlled Clin Trials 2:31\u201349, 1981","journal-title":"Controlled Clin Trials"},{"key":"BF02088245_CR53","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1001\/jama.1989.03430150069028","volume":"262","author":"A Nicolucci","year":"1989","unstructured":"Nicolucci A, Grilli R, Alexanian AA, Apolone G, Torri V, Liberati A: Quality, evolution, and clinical implications of randomized, controlled trials on the treatment of lung cancer: A lost opportunity for meta-analysis. JAMA 262:2101\u20132107, 1989","journal-title":"JAMA"},{"issue":"suppl 3","key":"BF02088245_CR54","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1423-0410.1994.tb04539.x","volume":"67","author":"HJ Alter","year":"1994","unstructured":"Alter HJ: Transfusion transmitted hepatitis C and non-A, non-B, non-C. Vox Sang 67(suppl 3):19\u201324, 1994","journal-title":"Vox Sang"},{"key":"BF02088245_CR55","doi-asserted-by":"crossref","first-page":"455","DOI":"10.7326\/0003-4819-118-6-199303150-00010","volume":"118","author":"GA Diamond","year":"1993","unstructured":"Diamond GA, Denton AT: Alternative perspectives on the biased foundations of medical technology assessment. Ann Intern Med 118:455\u2013464, 1993","journal-title":"Ann Intern Med"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02088245.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02088245\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02088245","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T00:44:55Z","timestamp":1586393095000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02088245"}},"subtitle":["A meta-analysis"],"short-title":[],"issued":{"date-parts":[[1996,6]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1996,6]]}},"alternative-id":["BF02088245"],"URL":"https:\/\/doi.org\/10.1007\/bf02088245","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,6]]}}}